Mirna Therapeutics
Biotechnology research and development company focused on miRNA-directed oncology therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
$167—251m (Dealroom.co estimates Apr 2015.)
Austin Texas (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $5.0m | Grant | |
N/A | $10.3m | Grant | |
N/A | $1.5m | Series B | |
$34.5m | Series C | ||
$41.8m | Series D | ||
$16.8m | Post IPO Equity | ||
N/A | N/A | IPO | |
Total Funding | $93.1m |
Related Content
Recent News about Mirna Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.